Latest News
Roche wins FDA clearance for customisable respiratory pathogen test
2 November 2026 - Healthcare company Roche (SIX: RO, ROP) (OTCQX: RHHBY) announced on Monday that it has received US Food and Drug Administration 510(k) clearance for its cobas eplex respiratory pathogen panel 3 (RP3), enabling laboratories to custom...
Abbott's Amulet 360 shows high LAA closure rates and low stroke incidence at one year
2 November 2026 - Healthcare company Abbott (NYSE: ABT) reported on Monday that it has achieved positive one-year results from the pivotal VERITAS study of its investigational Amulet 360 Left Atrial Appendage (LAA) Occluder, demonstrating high closur...
INOVIO's VOCERYQ receives US FDA accelerated approval to reduce surgery frequency in adults with RRP
2 November 2026 - INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercialising DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, announced on Friday that the US Food a...
Fresenius and WuXi Biologics agree biosimilars development partnership
2 November 2026 - Healthcare company Fresenius SE & Co KGaA (XETR: FRE) (OTCM: FSNUY) declared on Monday that it has signed an exclusive development agreement with research, development and manufacturing contract organisation WuXi Biologics (2269...
Abbott reports 30-day results from clinical trial of SonicForce Coronary IVL System
2 November 2026 - US healthcare company Abbott (NYSE:ABT) on Sunday reported strong 30-day results from the TECTONIC Coronary Artery Disease (CAD) Intravascular Lithotripsy (IVL) Investigational Device Exemption (IDE) Study evaluating the use of its ...